BOXAGRIPPAL cold tablets

Product Descriptions

In case of pain or fever, do not use longer than specified in the leaflet without medical advice. For risks and side effects, please read the leaflet and ask your doctor or pharmacist
BoxaGrippal 200mg/30mg

BoxaGrippal film-coated tablets are used for the symptomatic treatment of swelling of the mucous membranes of the nose and sinuses associated with headaches, fever and cold-related pain. BoxaGrippal film-coated tablets contain two active ingredients: ibuprofen and pseudoephedrine hydrochloride.

Areas of application: Symptomatic treatment of swelling of the mucous membranes of the nose and sinuses (rhinosinusitis) associated with headaches, fever and cold-related pain.

A notice:
The combination medicine should be used when both the decongestant (decongestant) effect of pseudoephedrine hydrochloride and the analgesic (pain-relieving) and/or antipyretic (fever-reducing) effect of ibuprofen are required. In situations where the symptoms predominantly consist of either pain/fever or nasal congestion, the use of medicines with an active ingredient is recommended.

Application and dosage:
Adults and adolescents aged 15 and over: 1 tablet every 6 hours for severe symptoms, 2 tablets every 6 hours (maximum daily dose: 6 tablets).
The maximum duration of use is 5 days.
Do not use during pregnancy and lactation.

Composition:
1 table contains:
Ibuprofen 200 mg pseudoephedrine hydrochloride 30 mg pseudoephedrine (equivalent) 24.58 mg lactose-1-water (HST) 84 mg cellulose microcrystalline (HST) carboxymethyl starch sodium type A (HST) silicon dioxide highly dispersed (HST) magnesium distearate (HST) poly(vinyl alcohol) ( HST) Titanium dioxide (HST) Macrogol 3350 (HST) Talc (HST)
Note: Contains lactose.

Source: Sano

ingredients / ingredients

1 film-coated tablet of Boxagrippal cold tablets 200 mg/30 mg Fta (pack size: 20 pieces) contains:




200 mg ibuprofen and 30 mg pseudoephedrine hydrochloride




other ingredients:

Lactose monohydrate, microcrystalline cellulose, sodium starch glycolate (type A), colloidal anhydrous silicon dioxide, magnesium stearate